REPL
Replimune Group, Inc. · Healthcare
Director Kapil Dhingra sold $33K of Replimune Group, Inc.
Sold$32,958
$10.40Price
3,169Shares
−100%Stake
What REPL did after the filing
- The stock from Fri, Dec 12 open, $9.84
- −25.2%
- S&P 500, same days
- +1.9%
Measured over 30 trading days, to the Jan 28 close.
Traded Tue, Dec 9. Filed Thu, Dec 11, 4:30 PM ET, after the close. Returns use the Dec 12 open and the Jan 28 close. Not investment advice.